Mental Retardation Clinical Trial
— COGNITUSOfficial title:
"Cognitus & Moi": a New Cognitive Remediation Tool for Children With Intellectual Deficiency With Behavioral Disorders
Verified date | August 2021 |
Source | Hôpital le Vinatier |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Holders children with intellectual disabilities have great difficulty in adapting to social situations and relationships.Cognitive impairment associated with intellectual disability are important factors to understand their difficulties in processing social information. In the field of recognition of facial emotions in particular, basic cognitive processes such as visuospatial and attentional functions, are heavily involved.Cognitive remediation is a management tool widely used by practitioners to help patients who experience cognitive difficulties. Currently, no program can meet specific and validated the problems are children with intellectual disabilities manner in their daily functioning.
Status | Terminated |
Enrollment | 18 |
Est. completion date | April 30, 2021 |
Est. primary completion date | April 30, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 5 Years to 13 Years |
Eligibility | Inclusion Criteria: - Children with intellectual deficiency (5-13 years) (40 < total IQ < 75) with or without autism spectrum disorders - Native French speaker - Clinically stable - Parental consent Exclusion Criteria: - visual or auditory disorder - history of neurological illness or trauma - Absence of language |
Country | Name | City | State |
---|---|---|---|
France | Demily Caroline | Bron | Lyon |
Lead Sponsor | Collaborator |
---|---|
Hôpital le Vinatier |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Aberrant Behavior Checklist scale | Change in sub-score " hyperactivity / non compliance " (scale " Aberrant Behavior Checklist ") (completed by parents or the educational team). This measure is repeated at the end of the intervention to highlight the impact of the " Cognitus and Me " program, and 6 months later to investigate the possible long-lasting effects of the benefits. | 6 months | |
Secondary | MDI-C scale ( Multiscore Depression Inventory for Children scale) | The Aberrant Behavior Checklist-Community (ABC-C; Aman & Singh, 1994) is a rating scale that measures the severity of a range of problem behaviors commonly observed in individuals with intellectual and developmental disabilities | 6 months | |
Secondary | KIDSCREEN-27 scale | The KIDSCREEN-27 with five dimensions resulted. All five dimensions are Rasch scales: Physical Well-Being (5 items), Psychological Well-Being (7 items), Autonomy & Parents (7 items), Peers & Social Support (4 items), and School Environment (4 items). | 6 months | |
Secondary | Vineland 2 scale (Vineland Adaptive Behavior Scale) | A measure of adaptive behavior from birth to adulthood | 6 months | |
Secondary | ABC scale (Irritability and social withdrawal) | This measure is repeated at the end of the intervention to highlight the impact of the " Cognitus and Me " program, and 6 months later to investigate the possible long-lasting effects of the benefits | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02791321 -
Fragility Assessment in Adults With ADHD and Mental Retardation
|
N/A | |
Recruiting |
NCT01908400 -
Safety and Efficacy of BMMNCin Patients With Mental Retardation
|
Phase 1/Phase 2 | |
Withdrawn |
NCT02245724 -
Stem Cell Therapy in Mental Retardation
|
Phase 1 | |
Completed |
NCT00156221 -
MR Scanning of Very Young Children With Severe Developmental Disorders
|
N/A | |
Recruiting |
NCT00491478 -
Repetitive Behavior Disorders in People With Severe Mental Retardation
|
Phase 3 | |
Completed |
NCT00758108 -
Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions
|
||
Completed |
NCT01430845 -
Predicting Developmental Disability Type and Mental Retardation Level in Children With General Developmental Delay
|
||
Not yet recruiting |
NCT02214745 -
Demographic Characteristics of Children Suffering From Mental Retardation or Cerebral Palsy in the Israeli Arab Community
|
N/A | |
Active, not recruiting |
NCT00552526 -
Ketogenic Diet vs.Antiepileptic Drug Treatment in Drug Resistant Epilepsy
|
Phase 4 | |
Completed |
NCT02943304 -
Neurodevelopment Outcome of Newborns Exposed to Zika Virus (ZIKV) in Utero
|
||
Completed |
NCT00491894 -
Safety and Efficacy Study of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Conditions
|
Phase 3 | |
Completed |
NCT01291238 -
School Intervention With Daily Physical Activity and Healthy Food for Students With an Intellectual Disability.
|
N/A | |
Completed |
NCT01456910 -
Resistance Training Program, Labor Inclusion, Intellectual Disability
|
N/A | |
Completed |
NCT00065273 -
Atypical Neuroleptic Drugs in People With Mental Retardation/Developmental Delay
|
Phase 3 | |
Active, not recruiting |
NCT00065936 -
Self-Injury: Diagnosis and Treatment
|
Phase 3 | |
Completed |
NCT00506259 -
Treatment Strategies for Children With Smith-Magenis Syndrome
|
Phase 1 | |
Not yet recruiting |
NCT05442229 -
A Cross-sectional Study to Evaluate Speech and Language Development in Chinese Children Aged 2-6 Years
|
||
Active, not recruiting |
NCT06370793 -
Ningbo Severe Mental Disorders Cohort
|
||
Completed |
NCT01517048 -
Brain-Derived Neurotrophic Factor in Obesity and Brain Function
|
||
Completed |
NCT03847753 -
Exploring the Comorbidity Between Mental Disorders and General Medical Conditions
|